Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi-Aventis Gets Priority Review For Second-Generation Atrial Fib Drug

11 Aug 2008

Approval could come in early 2009 for Cordarone successor Multaq.

Related Content

Solvay’s Pulzium Data Does Not Cross The Atlantic: FDA Panel Unanimously Opposes Approval

12 Dec 2007

Sanofi Dronedarone Re-Filing Anticipated In 2008 After FDA “Non Approvable” Letter

31 Aug 2006

Vernakalant, Cardiome Limelight Could Make ARYx Glow

20 Mar 2008

Sanofi-Aventis Heart Drug Multaq Back To FDA In Third Quarter

15 May 2008

ANDROMEDA Strain: Full Data Published From Multaq Trial

19 Jun 2008

Sanofi-Aventis Pares Pipeline, Ditches Antidepressant Amibegron

11 Aug 2008

Astellas/Cardiome’s Kynapid “Approvable”

11 Aug 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.